We use cookies to improve the use of this website. By clicking on "OK" you agree to the use of cookies. You can change your cookie settings at any time and receive further information regarding cookies here.
You are now leaving the Kedrion website. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES
HIGHLIGHTS
EVENTS
Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius
This new APP, presented at the IPIC Congress in Dubai, will be the personal assistant to people living with PIDs
read moreCORPORATE
IVIg efficacy in chronic inflammatory polyradiculoneuropathy (CIDP)
Continuous support by Kedrion Biopharma to research and partnering patient associations
read more-
EVENTS - 09-11-2017
Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius
This new APP, presented at the IPIC Congress in Dubai, will be the personal assistant to people living with PIDs
read more -
CORPORATE - 11-07-2017
Building Bridges: An eminent specialist diagnoses a patient in distress
Professor Hermann Wolf treats a special case in Vienna and Kedrion pitches in
read more -
CORPORATE - 17-12-2016
IVIg efficacy in chronic inflammatory polyradiculoneuropathy (CIDP)
Continuous support by Kedrion Biopharma to research and partnering patient associations
read more -
CORPORATE - 24-10-2016
Hemophilia seen through children's eyes: Kedrion teams up with LA Kelley
Three books of the series My First Factor Creation are now available for free download
read more
For more information please contact: pressoffice@kedrion.com
Where 